Since the firm's founding, Haug Partners has held a well-earned reputation for excellence in the life sciences, pairing the industry’s sharpest legal minds with a depth of experience that gets results for our clients. Clients trust Haug Partners in all aspects of their life science businesses. Whether a matter needs due-diligence, transactional, antitrust, regulatory, or life-cycle-management expertise, or a matter needs seasoned litigation, trial, or appellate counsel, Haug Partners has the experience.
As a technology-focused firm, Haug Partners has represented many of today’s pioneering pharmaceutical and biotech companies, including Takeda, Baxalta, Nektar, Supernus, Ipsen, and Celgene. We know that the intellectual property of a life science business is its lifeblood, driving its growth and its future. As scientists and engineers ourselves, we know full well what it takes to innovate and just how important it is to protect those innovations. Many of us have significant industry experience or advanced academic degrees or both in moleular + cellular biology, chemistry, biochemistry, and pharmacology.
This experience has led to many successes for our clients, including significant court victories on summary judgment, at trial and on appeal. Representative technical and industry experience include small-molecule drugs, peptide drugs, and other pharmaceutical products.